CAMP
Camp4 Therapeutics CorpCompany with tickers: CAMP
CIK
1736730
CUSIP
13463J101
Shares Outstanding
51,925,800
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | Tardiff Daniel | Chief Scientific Officer | Award | 170,000 |
| 2026-04-01 | Maricich Yuri | Chief Medical Officer | Award | 215,000 |
| 2026-04-01 | Gold Kelly | Chief Financial Officer | Award | 215,000 |
| 2026-04-01 | Mandel-Brehm Josh | Director, Chief Executive Officer | Award | 580,000 |
| 2026-04-01 | MacLean Michael F | Director | Award | 56,000 |
| 2026-04-01 | MacLean Michael F | Director | Other | 0 |
| 2025-12-11 | Tardiff Daniel | Chief Scientific Officer | Award | 145,500 |
| 2025-12-11 | Maricich Yuri | Chief Medical Officer | Award | 190,000 |
| 2025-12-11 | Gold Kelly | Chief Financial Officer | Award | 190,000 |
| 2025-12-11 | Mandel-Brehm Josh | Director, Chief Executive Officer | Award | 425,000 |
| 2025-10-01 | Tardiff Daniel | Chief Scientific Officer | Other | 0 |
| 2025-10-01 | Tardiff Daniel | Chief Scientific Officer | Other | 0 |
| 2025-10-01 | Tardiff Daniel | Chief Scientific Officer | Other | 0 |
| 2025-10-01 | Tardiff Daniel | Chief Scientific Officer | Other | 0 |
| 2025-09-11 | Schwab Andrew J. | Director, 10% Owner | Other | 2,625,145 |
| 2025-09-11 | Schwab Andrew J. | Director, 10% Owner | Other | 302,770 |
| 2025-09-11 | Schwab Andrew J. | Director, 10% Owner | Award | 2,941,176 |
| 2025-09-11 | 5AM Partners VI, LLC | 10% Owner | Other | 2,625,145 |
| 2025-09-11 | 5AM Partners VI, LLC | 10% Owner | Buy | 2,941,176 |
| 2025-09-11 | 5AM Partners VI, LLC | 10% Owner | Other | 302,770 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 909,090 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. | 10% Owner | Buy | 1,221,721 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. | 10% Owner | Buy | 85,468 |
| 2025-09-11 | Nashat Amir | Director | Buy | 1,221,721 |
| 2025-09-11 | Nashat Amir | Director | Buy | 85,468 |
| 2025-09-11 | Nashat Amir | Director | Other | 909,090 |
| 2025-09-11 | Maricich Yuri | Chief Medical Officer | Buy | 6,060 |
| 2025-09-11 | Gold Kelly | Chief Financial Officer | Buy | 6,060 |
| 2025-09-11 | Mandel-Brehm Josh | Director, Chief Executive Officer | Buy | 6,060 |
| 2025-09-11 | Young Richard A | Director | Buy | 15,151 |
| 2025-06-25 | Boylan James P | Director | Award | 9,000 |
| 2025-06-25 | Young Richard A | Director | Award | 9,000 |
| 2025-06-25 | Higgins Michael J | Director | Award | 9,000 |
| 2025-06-25 | Schwab Andrew J. | Director, 10% Owner | Award | 9,000 |
| 2025-06-25 | Holtzman Steven H | Director | Award | 9,000 |
| 2025-06-25 | Nashat Amir | Director | Award | 9,000 |
| 2025-06-25 | Thadhani Ravi I. | Director | Award | 9,000 |
| 2025-06-25 | Ragan Paula | Director | Award | 9,000 |
| 2025-04-01 | Bumcrot David | Chief Scientific Officer | Award | 45,000 |
| 2025-04-01 | Maricich Yuri | Chief Medical Officer | Award | 80,000 |
| 2025-04-01 | Gold Kelly | Chief Financial Officer | Award | 80,000 |
| 2025-04-01 | Mandel-Brehm Josh | Director, Chief Executive Officer | Award | 160,000 |
| 2025-03-17 | WILLIAMS DOUGLAS E | Director | Award | 17,787 |
| 2025-03-17 | Stewart Murray | Director | Award | 17,787 |
| 2025-03-17 | Stewart Murray | Director | Other | 0 |
| 2025-03-17 | WILLIAMS DOUGLAS E | Director | Other | 0 |
| 2024-10-15 | Northpond Ventures II GP, LLC | 10% Owner | Buy | 763,636 |
| 2024-10-15 | Northpond Ventures II GP, LLC | 10% Owner | Other | 471,415 |
| 2024-10-15 | Northpond Ventures II GP, LLC | 10% Owner | Other | 5,287,303 |
| 2024-10-15 | Northpond Ventures II GP, LLC | 10% Owner | Other | 11,251,624 |
| 2024-10-15 | Northpond Ventures II GP, LLC | 10% Owner | Other | 1,003,193 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. | 10% Owner | Buy | 545,454 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. | 10% Owner | Other | 1,398,067 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. | 10% Owner | Buy | 181,818 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. | 10% Owner | Other | 679,163 |
| 2024-10-15 | AH Equity Partners Bio I, L.L.C. | 10% Owner | Other | 15,001,312 |
| 2024-10-15 | Enavate Sciences GP, LLC | 10% Owner | Other | 2,422,166 |
| 2024-10-15 | Enavate Sciences GP, LLC | 10% Owner | Buy | 1,363,636 |
| 2024-10-15 | Enavate Sciences GP, LLC | 10% Owner | Other | 27,166,530 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Other | 1,337,592 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Other | 302,770 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Other | 378,463 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Other | 15,002,166 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Other | 3,395,816 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Other | 4,244,770 |
| 2024-10-15 | Schwab Andrew J. | Director, 10% Owner | Buy | 909,090 |
| 2024-10-15 | Holtzman Steven H | Director | Other | 8,917 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 1,250,061 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 277,536 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 980,829 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 3,967,234 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 87,448 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 24,745 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Buy | 909,090 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 14,020,475 |
| 2024-10-15 | Polaris Management Co. VII, L.L.C. | 10% Owner | Other | 353,718 |
| 2024-10-15 | 5AM Partners VI, LLC | 10% Owner | Other | 3,395,816 |
| 2024-10-15 | 5AM Partners VI, LLC | 10% Owner | Other | 1,716,055 |
| 2024-10-15 | 5AM Partners VI, LLC | 10% Owner | Other | 302,770 |
| 2024-10-15 | 5AM Partners VI, LLC | 10% Owner | Buy | 909,090 |
| 2024-10-15 | 5AM Partners VI, LLC | 10% Owner | Other | 15,002,166 |
| 2024-10-15 | 5AM Partners VI, LLC | 10% Owner | Other | 4,244,770 |
| 2024-10-15 | Nashat Amir | Director | Other | 24,745 |
| 2024-10-15 | Nashat Amir | Director | Buy | 909,090 |
| 2024-10-15 | Nashat Amir | Director | Other | 87,448 |
| 2024-10-15 | Nashat Amir | Director | Other | 353,718 |
| 2024-10-15 | Nashat Amir | Director | Other | 14,020,475 |
| 2024-10-15 | Nashat Amir | Director | Other | 1,250,061 |
| 2024-10-15 | Nashat Amir | Director | Other | 980,829 |
| 2024-10-15 | Nashat Amir | Director | Other | 277,536 |
| 2024-10-15 | Nashat Amir | Director | Other | 3,967,234 |
| 2024-10-15 | Young Richard A | Director | Other | 100,014 |
| 2024-10-15 | Young Richard A | Director | Other | 8,917 |
| 2024-10-15 | Mandel-Brehm Josh | Director, Chief Executive Officer | Other | 6,791 |
| 2024-10-15 | Mandel-Brehm Josh | Director, Chief Executive Officer | Other | 605 |
| 2024-10-15 | Polaris Partners GP X, L.L.C. | 10% Owner | Other | 909,090 |
| 2024-10-15 | Holtzman Steven H | Director | Other | 100,014 |
| 2024-10-10 | Enavate Sciences GP, LLC | 10% Owner | Other | 0 |
| 2024-10-10 | Maricich Yuri | Chief Medical Officer | Other | 0 |
| 2024-10-10 | Schwab Andrew J. | Director, 10% Owner | Other | 0 |